Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Mar
31
The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025
Mar
28
Join UCB at the MGFA National Patient Conference and Visit Our Experience Room
Mar
27
UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Mar
19
New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
Mar
12
Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome
Mar
07
Improving Dermatology Outcomes with Timely Diagnosis and Long-Lasting Treatment Options
Mar
07
BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden
Mar
07
BIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-Term Efficacy in Moderate-to-Severe Plaque Psoriasis
Mar
05
Voices on Value: Prioritizing Patients Now and Into the Future
